[
  {
    "cluster": 1,
    "content": "TITLE: Item 8.01\nTEXT: Item 8.01 Other Events. On September 5, 2025, as required by the Warrant and Common Stock Agreement, dated as of August 22, 2025 (the “Purchase Agreement”), by and between Intel Corporation (the “Company”) and the United States Department of Commerce (the “selling securityholder”), the Company filed a prospectus supplement with the Securities and Exchange Commission (the “SEC”) solely to register the potential resale by the selling securityholder of (i) a warrant to purchase up to 240,516,150 shares of the Company’s common stock, par value $0.001 per share (the “common stock”) at an initial exercise price of $20.00 per share (the “Warrant”) and (ii) 673,839,150 shares of common stock. The shares of common stock represent (x) 274,583,000 shares issued to the selling securityholder pursuant to the Purchase Agreement, (y) 158,740,000 shares issued into escrow for the benefit of the selling securityholder subject to the satisfaction of certain escrow conditions set forth in the Purchase Agreement and (z) 240,516,150 shares issuable to the selling securityholder should it choose to exercise the Warrant. This description is not complete and is subject to, and qualified in its entirety by reference to the full text of, the Form of Warrant and the Purchase Agreement attached as Exhibits 4.1 and 10.1, respectively, to our Current Report on Form 8-K filed with the SEC on August 25, 2025, and incorporated herein by reference. On September 5, 2025, as required by the Warrant and Common Stock Agreement, dated as of August 22, 2025 (the “Purchase Agreement”), by and between Intel Corporation (the “Company”) and the United States Department of Commerce (the “selling securityholder”), the Company filed a prospectus supplement with the Securities and Exchange Commission (the “SEC”) solely to register the potential resale by the selling securityholder of (i) a warrant to purchase up to 240,516,150 shares of the Company’s common stock, par value $0.001 per share (the “common stock”) at an initial exercise price of $20.00 per share (the “Warrant”) and (ii) 673,839,150 shares of common stock. The shares of common stock represent (x) 274,583,000 shares issued to the selling securityholder pursuant to the Purchase Agreement, (y) 158,740,000 shares issued into escrow for the benefit of the selling securityholder subject to the satisfaction of certain escrow conditions set forth in the Purchase Agreement and (z) 240,516,150 shares issuable to the selling securityholder should it choose to exercise the Warrant. This description is not complete and is subject to, and qualified in its entirety by reference to the full text of, the Form of Warrant and the Purchase Agreement attached as Exhibits 4.1 and 10.1, respectively, to our Current Report on Form 8-K filed with the SEC on August 25, 2025, and incorporated herein by reference. The filing of the resale prospectus supplement is not itself a sale of securities by the selling securityholder and does not necessarily mean that the selling securityholder will choose to sell any shares of common stock or the Warrant. If any shares of common stock or the Warrant are sold by the selling securityholder, the Company would not receive any proceeds from that sale. No securities will be issued or sold by the Company pursuant to the resale prospectus supplement. The filing of the resale prospectus supplement is not itself a sale of securities by the selling securityholder and does not necessarily mean that the selling securityholder will choose to sell any shares of common stock or the Warrant. If any shares of common stock or the Warrant are sold by the selling securityholder, the Company would not receive any proceeds from that sale. No securities will be issued or sold by the Company pursuant to the resale prospectus supplement. The resale prospectus supplement was filed pursuant to the Company’s automatic “shelf” Registration Statement on Form S-3ASR (File No. 333-269522), previously filed with the SEC on February 2, 2023. The Company is filing this current report to provide the legal opinion as to the validity of the shares of common stock and the Warrant covered by the resale prospectus supplement, which opinion is attached hereto as Exhibit 5.1 and is incorporated herein by reference. The resale prospectus supplement was filed pursuant to the Company’s automatic “shelf” Registration Statement on Form S-3ASR (File No. 333-269522), previously filed with the SEC on February 2, 2023. The Company is filing this current report to provide the legal opinion as to the validity of the shares of common stock and the Warrant covered by the resale prospectus supplement, which opinion is attached hereto as Exhibit 5.1 and is incorporated herein by reference.\n"
  },
  {
    "cluster": 2,
    "content": "TITLE: Item 9.01\nTEXT: Item 9.01 Financial Statements and Exhibits. Financial Statements and Exhibits. The following exhibits are provided as part of this report: The following exhibits are provided as part of this report: Exhibit NumberDescription5.1Opinion of Skadden, Arps, Slate, Meagher & Flom LLP23.1Consent of Skadden, Arps, Slate, Meagher & Flom LLP (included in Exhibit 5.1)104Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101. Exhibit NumberDescription5.1Opinion of Skadden, Arps, Slate, Meagher & Flom LLP23.1Consent of Skadden, Arps, Slate, Meagher & Flom LLP (included in Exhibit 5.1)104Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101. Exhibit NumberDescription5.1Opinion of Skadden, Arps, Slate, Meagher & Flom LLP23.1Consent of Skadden, Arps, Slate, Meagher & Flom LLP (included in Exhibit 5.1)104Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101. Exhibit NumberDescription 5.1Opinion of Skadden, Arps, Slate, Meagher & Flom LLP Opinion of Skadden, Arps, Slate, Meagher & Flom LLP Opinion of Skadden, Arps, Slate, Meagher & Flom LLP Opinion of Skadden, Arps, Slate, Meagher & Flom LLP Opinion of Skadden, Arps, Slate, Meagher & Flom LLP 23.1Consent of Skadden, Arps, Slate, Meagher & Flom LLP (included in Exhibit 5.1) Consent of Skadden, Arps, Slate, Meagher & Flom LLP (included in Exhibit 5.1) Consent of Skadden, Arps, Slate, Meagher & Flom LLP (included in Exhibit 5.1) 104Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101. Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101. Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101. Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INTEL CORPORATION(Registrant)Date:September 5, 2025By:/s/ April Miller BoiseApril Miller BoiseExecutive Vice President and Chief Legal Officer INTEL CORPORATION(Registrant)Date:September 5, 2025By:/s/ April Miller BoiseApril Miller BoiseExecutive Vice President and Chief Legal Officer INTEL CORPORATION(Registrant)Date:September 5, 2025By:/s/ April Miller BoiseApril Miller BoiseExecutive Vice President and Chief Legal Officer INTEL CORPORATION(Registrant) INTEL CORPORATION(Registrant) Date:September 5, 2025By:/s/ April Miller Boise /s/ April Miller Boise /s/ April Miller Boise Executive Vice President and Chief Legal Officer Executive Vice President and Chief Legal Officer Executive Vice President and Chief Legal Officer\n"
  }
]